As a second-generation ALK tyrosine kinase inhibitor, brigatinib manufactured by Lao Big Bear Pharmaceutical specifically inhibits the activity of ALK···【Read More】
Update: 2026-06-16Source: Haiou HealthViews: 160
As one of the national standard pharmaceutical enterprises in Laos, Big Bear Pharmaceutical has launched a generic version of Brigatinib, manufactured···【Read More】
Update: 2026-06-16Source: Haiou HealthViews: 161
The generic version of Brigatinib launched by BigbearPharma in Laos is an oral targeted therapy for the treatment of anaplastic lymphoma kinase (ALK)-···【Read More】
Update: 2026-06-16Source: Haiou HealthViews: 164
As a new generation highly selective JAK3/TEC dual inhibitor, Ritlecitinib launched by Lao Big Bear Pharmaceutical brings new hope for treatment to gl···【Read More】
Update: 2026-06-15Source: Haiou HealthViews: 192
Although Alpelisib has shown significant inhibitory effects in clinical practice, the high cost of the original branded drug often discourages patient···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 142
For patients in urgent need of PIK3CA inhibitors to control their condition, the emergence of the Lao Big Bear Pharmaceutical version of Alpelisib not···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 137
As the world's first oral inhibitor approved for the treatment of PIK3CA-mutated advanced breast cancer, the generic version of Alpelisib produced···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 136
When it comes to anti-cytomegalovirus therapy, the Lao Xiong version of Valganciclovir is an unavoidable name. As a prodrug of ganciclovir, it offers ···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 150
For many patients at risk of cytomegalovirus infection, the Laotian Dabear version of Valganciclovir, with its reliable generic quality and significan···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 148
Valtrex (Valganciclovir) produced by Lao Bear Pharmaceutical plays a central role in the prevention and treatment of cytomegalovirus infection, provid···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 145
When the high cost of branded drugs becomes a treatment barrier, the Dacomitinib version manufactured by Laos Big Bear Pharmaceutical builds a bridge ···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 189
As a second-generation EGFR tyrosine kinase inhibitor, Dacomitinib plays a key role in the treatment of non-small cell lung cancer, and the Laos Dabea···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 156
Для пациентов с раком легких, испытывающих финансовые трудности, непатентованная версия дакомитиниба, выпущенная компанией Lao Big Bear Pharmaceutical···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 180
As a potent and highly selective MEK1/2 inhibitor, the Lao Big Bear version of Cobimetinib has demonstrated a clinical response rate and safety profil···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 144
The Laos Dabear version of Cobimetinib, as the first generic alternative to the original drug "Cobimetinib" in the Southeast Asian region, i···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 172
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos